VGHCX holdings (2026)
Holdings as of Jul 31, 2026, the fund’s latest SEC filing; weights are ChartRow estimates at today’s prices.
Holdings 92 · Top 10 42% · Largest LLY 9.8% · Median P/E 27.5 · Yield 1.04% · Avg cap $289B
Top 10 holdings#
Data provided bySource: Twelve DataSector weights#
Sectors · Healthcare 88.5% · all 2
- Healthcare 88.5%
- Not on ChartRow 11.5%
Loading this view…
It has not arrived yet. Try again or show the table.
VGHCX holdings by weight#
1–92 of 92Delayed prices refresh in ~ min · Upgrade to Pro for real-time prices →Upgrade to Pro →Upgrade →
Last close only · intraday with Pro →
Mutual funds · intraday prices aren't available
Columns6 cols
VGHCX's holdings, ranked by weight, highest first: a table of est. weight, price, 1D, YTD total, 1Y total and mkt cap / AUM.
| Company | ||||||
|---|---|---|---|---|---|---|
| LLYEli Lilly | 9.80% | $1,443.50 | +1.14% | +35.1% | ||
| MRKMerck | 5.59% | $147.76 | +0.55% | +43.3% | ||
| JNJJohnson & Johnson | 4.88% | $285.75 | +0.79% | +40.3% | ||
| AZNAstraZeneca | 4.52% | $184.45 | +0.04% | +1.4% | ||
| UNHUnitedHealth Group | 3.61% | $407.46 | +0.58% | +25.9% | ||
| EWEdwards Lifesciences | 2.89% | $107.15 | +1.28% | +25.7% | ||
| ISRGIntuitive Surgical | 2.87% | $443.59 | +0.84% | -21.7% | ||
| GSKGSK ADR | 2.65% | $50.45 | -0.38% | +6.5% | ||
| CORCencora | 2.58% | $359.03 | +2.76% | +6.9% | ||
| ABBVAbbVie | 2.45% | $295.03 | +0.20% | +33.0% | ||
| REGNRegeneron Pharmaceuticals | 2.43% | $955.47 | +0.45% | +24.3% | ||
| VRTXVertex Pharmaceuticals | 2.42% | $538.60 | -0.74% | +18.8% | ||
| DHRDanaher | 2.36% | $233.02 | +0.37% | +2.4% | ||
| CVSCVS Health | 1.95% | $89.35 | -0.49% | +16.0% | ||
| ELVElevance Health | 1.89% | $429.69 | -0.05% | +24.4% | ||
| HCAHCA Healthcare | 1.89% | $499.05 | -0.32% | +7.5% | ||
| NVSNovartis | 1.78% | $160.50 | +0.16% | +20.0% | ||
| ARGXargenx ADR | 1.71% | $960.04 | -2.17% | +14.2% | ||
| AAgilent Technologies | 1.70% | $173.96 | +0.55% | +28.8% | ||
| BIIBBiogen | 1.65% | $253.40 | +1.17% | +44.0% | ||
| GMABGenmab ADR | 1.55% | $51.37 | -0.72% | +66.8% | ||
| UCB SA | 1.51% | — | — | — | ||
| BSXBoston Scientific | 1.31% | $44.34 | +0.32% | -53.5% | ||
| CAHCardinal Health | 1.27% | $281.10 | +1.06% | +38.1% | ||
| Galderma Group AG | 1.24% | — | — | — | ||
| MRNAModerna | 1.24% | $223.37 | -3.45% | +657.4% | ||
| AMGNAmgen | 1.09% | $465.67 | -0.30% | +45.2% | ||
| Roche Holding AG | 1.07% | — | — | — | ||
| DXCMDexCom | 1.06% | $83.33 | +2.38% | +25.6% | ||
| CNCCentene | 1.04% | $71.27 | +1.42% | +73.2% | ||
| MDTMedtronic plc. | 1.03% | $102.86 | +1.85% | +9.8% | ||
| UTHRUnited Therapeutics | 1.01% | $591.17 | -0.36% | +21.3% | ||
| ABTAbbott Laboratories | 0.96% | $108.52 | +1.18% | -11.2% | ||
| Shionogi & Co Ltd | 0.92% | — | — | — | ||
| Otsuka Holdings Co Ltd | 0.89% | — | — | — | ||
| Daiichi Sankyo Co Ltd | 0.87% | — | — | — | ||
| Chugai Pharmaceutical Co Ltd | 0.85% | — | — | — | ||
| ALNYAlnylam Pharmaceuticals | 0.84% | $165.04 | +5.36% | -58.5% | ||
| RVMDRevolution Medicines | 0.81% | $172.29 | -2.30% | +116.3% | ||
| SYKStryker | 0.80% | $309.64 | -0.88% | -11.1% | ||
| TMOThermo Fisher Scientific | 0.76% | $700.22 | +0.11% | +21.2% | ||
| ASNDAscendis Pharma | 0.72% | $275.39 | +3.12% | +29.1% | ||
| STESTERIS | 0.69% | $264.32 | +4.29% | +5.2% | ||
| INCYIncyte | 0.68% | $120.97 | -0.60% | +22.5% | ||
| HTFLHeartflow | 0.67% | $48.46 | -19.13% | +66.2% | ||
| QIAGEN NV | 0.59% | — | — | — | ||
| BBIOBridgeBio Pharma | 0.59% | $78.30 | +0.17% | +2.4% | ||
| MDGLMadrigal Pharmaceuticals | 0.57% | $427.39 | +0.51% | -26.6% | ||
| KYMRKymera Therapeutics | 0.54% | $127.57 | +0.31% | +64.0% | ||
| Eisai Co Ltd | 0.52% | — | — | — | ||
| OPCHOption Care Health | 0.51% | $31.65 | -0.09% | -0.7% | ||
| CGONCG Oncology | 0.50% | $74.40 | +6.06% | +79.2% | ||
| HSBC Bank USA | 0.48% | — | — | — | ||
| BMYBristol-Myers Squibb | 0.46% | $63.43 | +1.78% | +22.8% | ||
| CYTKCytokinetics | 0.45% | $56.13 | -0.05% | -11.7% | ||
| ICLRICON | 0.43% | $194.65 | -2.92% | +6.8% | ||
| IONSIonis Pharmaceuticals | 0.43% | $29.06 | +6.41% | -63.3% | ||
| EHCEncompass Health | 0.42% | $140.99 | +0.11% | +33.8% | ||
| SRRKScholar Rock Holding | 0.40% | $43.21 | +0.10% | -1.9% | ||
| PTGXProtagonist Therapeutics | 0.39% | $130.95 | -2.55% | +49.9% | ||
| Natixis SA | 0.36% | — | — | — | ||
| PCVXVaxcyte | 0.35% | $63.37 | -2.04% | +37.3% | ||
| PTCTPTC Therapeutics | 0.35% | $63.49 | +0.21% | -16.4% | ||
| BNP Paribas Securities Corp. | 0.34% | — | — | — | ||
| NVONovo Nordisk | 0.33% | $41.63 | +2.41% | -14.1% | ||
| DNTHDianthus Therapeutics | 0.33% | $91.81 | -0.72% | +122.8% | ||
| INSPInspire Medical Systems | 0.30% | $61.10 | +0.92% | -33.8% | ||
| IMCRImmunocore Holdings ADR | 0.30% | $29.94 | -1.76% | -13.7% | ||
| CLDXCelldex Therapeutics | 0.26% | $28.83 | +1.05% | +6.1% | ||
| M3 Inc | 0.25% | — | — | — | ||
| ZLABZai Lab ADR | 0.21% | $24.60 | -5.53% | +39.5% | ||
| Nomura Securities International, Inc. | 0.20% | — | — | — | ||
| ZBIOZenas BioPharma | 0.20% | $28.01 | +1.34% | -22.9% | ||
| Bank of America Securities, LLC | 0.18% | — | — | — | ||
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 0.17% | — | — | — | ||
| IMNMImmunome | 0.16% | $18.77 | +0.37% | -12.6% | ||
| GPCRStructure Therapeutics ADR | 0.16% | $20.00 | +0.81% | -71.2% | ||
| GenFleet Therapeutics Shanghai Inc | 0.16% | — | — | — | ||
| Duality Biotherapeutics Inc | 0.15% | — | — | — | ||
| Bank of Nova Scotia | 0.15% | — | — | — | ||
| STOKStoke Therapeutics | 0.14% | $26.68 | +1.83% | -15.9% | ||
| RCUSArcus Biosciences | 0.14% | $17.43 | -1.91% | -26.9% | ||
| Barclays Capital Inc. | 0.14% | — | — | — | ||
| JP Morgan Securities LLC | 0.13% | — | — | — | ||
| Vanguard Cmt Funds-Vanguard Market Liquidity Fund | 0.12% | — | — | — | ||
| ALHCAlignment Healthcare | 0.12% | $7.36 | -1.87% | -62.7% | ||
| DYNDyne Therapeutics | 0.11% | $17.16 | +0.88% | -12.3% | ||
| Pharvaris NV | 0.09% | — | — | — | ||
| Shandong Weigao Group Medical Polymer Co Ltd | 0.08% | — | — | — | ||
| Aktis Oncology Inc | 0.08% | — | — | — | ||
| KLRAKailera Therapeutics | 0.07% | $13.27 | +0.45% | — | ||
| DFTXDefinium Therapeutics | 0.06% | $32.08 | -2.79% | +139.6% |
Estimated portfolio characteristics#
Data provided bySource: Twelve DataEstimated by our own bottom-up analysis of the fund’s SEC-filed holdings, covering 88% of portfolio weight (89% carries a valid trailing P/E). Funds publish similar figures on their own sites; ours are recomputed daily from public data.
Methodology#
Holdings and weights are sourced from the fund’s portfolio as disclosed to the SEC on Form N-PORT — a public filing. Portfolio filings are quarterly (public ~60 days after quarter end), so we anchor on the latest one and roll each weight forward daily by that holding’s price move, keeping the numbers current between filings; positions in stocks ChartRow doesn’t track carry their filed weight unchanged and show “—” where we have no data. Returns are total returns (dividends reinvested). One row per company, not per ticker: when a fund holds more than one share class of the same company (Alphabet’s GOOGL and GOOG, for example), we combine them into a single row whose weight is the sum of its classes. Past performance does not predict future returns; not investment advice.
FAQ#
- What are the top 10 holdings of VGHCX?
- VGHCX's top 10 holdings are Eli Lilly and Company (LLY), 9.8%; Merck & Co. Inc. (MRK), 5.6%; Johnson & Johnson (JNJ), 4.9%; AstraZeneca PLC (AZN), 4.5%; UnitedHealth Group Incorporated Common Stock (DE) (UNH), 3.6%; Edwards Lifesciences Corporation (EW), 2.9%; Intuitive Surgical Inc. (ISRG), 2.9%; GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK), 2.7%; Cencora Inc. (COR), 2.6%; AbbVie Inc. (ABBV), 2.5% — together about 42% of the fund, per its Jul 31, 2026 SEC filing with weights rolled forward to today.
- How many holdings does VGHCX have?
- Vanguard Health Care Fund Investor Shares (VGHCX) held 92 positions as of Jul 31, 2026, the date of its latest public portfolio report to the SEC.
- How current are VGHCX's holdings?
- The list of holdings is as of Jul 31, 2026. Funds report their full portfolio to the SEC on Form N-PORT, and the report for the last month of each fiscal quarter becomes public about 60 days after that month ends, so the newest public portfolio is always two to five months old. Between reports ChartRow updates each weight daily by that holding's price move, so the weights estimate today; the positions themselves change only when the next report is published. A fund's own website may list more recent holdings.
- Is ChartRow affiliated with VGHCX or Vanguard?
- No. ChartRow is independent and is not affiliated with, sponsored by, or endorsed by Vanguard or Vanguard Health Care Fund Investor Shares. Everything on this page is derived independently from the fund's public SEC filings; fund names and trademarks belong to their owners. For information only — not investment advice.